Skip to content

Clinical trials

Observational Hypoparathyroidism trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Phase: Observational Country / region: France Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20162
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospices Civils de Lyon2
Aix Marseille Université1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Central Hospital, Nancy, France1
Centre Hospitalier Universitaire de Nīmes1
European Georges Pompidou Hospital1
Nantes University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism8
Hypocalcemia2
Calcium Metabolism Disorders1
Fibrous Dysplasia of Bone1
Fibrous Dysplasia, Polyostotic1
Hypercalciuria1
Hyperparathyroidism1
Metabolic Diseases1
Muscular Diseases1
Musculoskeletal Abnormalities1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.